1.           Introduction

1.1       Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1         Hypothesis formulation:

3.2.2         Macro-economic factor analysis:

3.2.3         Developing base number:

3.2.4         Data Triangulation:

3.2.5         Country level data:

4.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Landscape

4.1       Overview

4.2       PEST Analysis

4.3       Benefits of ePROs

4.4       Use of ePRO in Clinical Trials

5.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Key Market Dynamics

5.1       South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Key Market Dynamics

5.2       Market Drivers:

5.2.1         Emerging Applications of Electronic Patient-Reported Outcomes (ePROS)

5.2.2         Increasing Focus on Patient-Centered Care

5.3       Market Restraints

5.3.1         Data Privacy and Security Issues

5.4       Market Opportunities

5.4.1         Rising Adoption of Telehealth and Remote Monitoring

5.5       Future Trends

5.5.1         Integration of Artificial Intelligence and Machine Learning with ePROS Platforms

5.6       Impact of Drivers and Restraints:

6.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Analysis

6.1       South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Revenue (US$ Million), 2021–2031

6.2       South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Forecast Analysis

7.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by Delivery Mode

7.1       Cloud Based

7.1.1         Overview

7.1.2         Cloud Based: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2       On-Premise

7.2.1         Overview

7.2.2         On-Premise: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by Application

8.1       Oncology

8.1.1         Overview

8.1.2         Oncology: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2       Respiratory

8.2.1         Overview

8.2.2         Respiratory: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.3       Others

8.3.1         Overview

8.3.2         Others: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by End User

9.1       CROs

9.1.1         Overview

9.1.2         CROs: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.2       Pharmaceutical Companies

9.2.1         Overview

9.2.2         Pharmaceutical Companies: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.3       Others

9.3.1         Overview

9.3.2         Others: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.        South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Country Analysis

10.1     South & Central America

10.1.1       South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country

10.1.1.1          South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country

10.1.1.2          Brazil: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.2.1        Brazil: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share – by Delivery Mode

10.1.1.2.2        Brazil: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share – by Application

10.1.1.2.3        Brazil: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share – by End User

10.1.1.3          Argentina: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.3.1        Argentina: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share – by Delivery Mode

10.1.1.3.2        Argentina: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share – by Application

10.1.1.3.3        Argentina: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share – by End User

10.1.1.4          Rest of South & Central America: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.4.1        Rest of South & Central America: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share – by Delivery Mode

10.1.1.4.2        Rest of South & Central America: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share – by Application

10.1.1.4.3        Rest of South & Central America: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share – by End User

11.        Industry Landscape

11.1     Overview

11.2     Market Initiative

11.3     Partnerships and Collaborations

12.        Company Profiles

12.1     OpenClinica LLC

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2     Buddy Healthcare Ltd Oy

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3     Castor

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4     Medable Inc

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5     Assistek

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6     Signant Health

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7     Crucial Data Solutions

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8     Curebase

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Products and Services

12.8.4       Financial Overview

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9     Y-Prime LLC

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Products and Services

12.9.4       Financial Overview

12.9.5       SWOT Analysis

12.9.6       Key Developments

12.10  Clinical Ink Inc

12.10.1    Key Facts

12.10.2    Business Description

12.10.3    Products and Services

12.10.4    Financial Overview

12.10.5    SWOT Analysis

12.10.6    Key Developments

12.11  Medidata Solutions

12.11.1    Key Facts

12.11.2    Business Description

12.11.3    Products and Services

12.11.4    Financial Overview

12.11.5    SWOT Analysis

12.11.6    Key Developments

12.12  Veeva Systems Inc

12.12.1    Key Facts

12.12.2    Business Description

12.12.3    Products and Services

12.12.4    Financial Overview

12.12.5    SWOT Analysis

12.12.6    Key Developments

12.13  Medrio

12.13.1    Key Facts

12.13.2    Business Description

12.13.3    Products and Services

12.13.4    Financial Overview

12.13.5    SWOT Analysis

12.13.6    Key Developments

12.14  PatientIQ

12.14.1    Key Facts

12.14.2    Business Description

12.14.3    Products and Services

12.14.4    Financial Overview

12.14.5    SWOT Analysis

12.14.6    Key Developments

13.        Appendix

13.1     About Us

13.2     List of Abbreviations

List of Tables

Table 1.             South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Segmentation

Table 2.             South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 3.             South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Delivery Mode

Table 4.             South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application

Table 5.             South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million) – by End User

Table 6.             South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 7.             Brazil: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Delivery Mode

Table 8.             Brazil: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Application

Table 9.             Brazil: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by End User

Table 10.          Argentina: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Delivery Mode

Table 11.          Argentina: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Application

Table 12.          Argentina: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by End User

Table 13.          Rest of South & Central America: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Delivery Mode

Table 14.          Rest of South & Central America: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Application

Table 15.          Rest of South & Central America: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by End User

Table 16.          List of Abbreviations

List of Figures

Figure 1.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Segmentation – Country

Figure 2.           PEST Analysis

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Revenue (US$ Million), 2021–2031

Figure 5.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share (%) – by Delivery Mode (2023 and 2031)

Figure 6.           Cloud Based: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 7.           On-Premise: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8.           South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share (%) – by Application (2023 and 2031)

Figure 9.           Oncology: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 10.        Respiratory: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11.        Others: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12.        South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Share (%) – by End User (2023 and 2031)

Figure 13.        CROs: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 14.        Pharmaceutical Companies: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 15.        Others: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16.        South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 17.        Brazil: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 18.        Argentina: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 19.        Rest of South & Central America: South & Central America Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast, 2021– 2031 (US$ Million)